Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed.
Fiala O, Hosek P, Pesek M, Finek J, Racek J, Buchler T, Poprach A, Hejduk K, Chloupkova R, Sorejs O, Ecksteinova M, Vitovec M, Cizkova K, Kucera R, Topolcan O.
Fiala O, et al. Among authors: hosek p.
Neoplasma. 2017;64(4):605-610. doi: 10.4149/neo_2017_416.
Neoplasma. 2017.
PMID: 28485168